Big Gain For PHAXIAM Therapeutics S.A.
Thu, Aug 10, 2023 at 07:29 PM
PHAXIAM Therapeutics S.A. (PHXM:NASDAQ) shot up at $0.59, representing a gain of 36.3%. On Thu, Aug 10, 2023, PHXM:NASDAQ touched a New 2-Week Intraday High of $0.67. From Thu, Jul 27, 2023, the stock recorded 20.00% Up Days and 36.36% Green Days
About PHAXIAM Therapeutics S.A. (PHXM:NASDAQ)
Erytech Pharma SA is a clinical-stage biopharmaceutical company developing innovative therapies for severe forms of cancer and orphan diseases.
Top 10 Gainers:
- Black Spade Acquisition Co Class A (BSAQ:NYSEMKT), 73.06%
- Black Spade Acquisition Co Class A (BSAQ:NYSE), 73.06%
- Capri Holdings Limited (CPRI:NYSE), 55.74%
- WeWork Inc. Class A (WE:NYSE), 43.44%
- Science 37 Holdings Inc. (SNCE:NASDAQ), 42.09%
- PHAXIAM Therapeutics S.A. (PHXM:NASDAQ), 36.34%
- Edible Garden AG Incorporated (EDBL:NASDAQ), 29.41%
- Beneficient (BENF:NASDAQ), 27.81%
- Applovin Corporation (APP:NASDAQ), 26.49%
- EzFill Holdings Inc. (EZFL:NASDAQ), 25.65%